Published in Diagn Microbiol Infect Dis on May 01, 1986
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol (1991) 2.51
Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19
Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol (1993) 1.77
Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays. J Clin Microbiol (1992) 1.49
Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease. J Clin Microbiol (1991) 1.36
Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol (1992) 1.19
Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A. J Clin Pathol (1997) 0.80
Presumptive identification of Clostridium difficile by detection of p-cresol in prepared peptone yeast glucose broth supplemented with p-hydroxyphenylacetic acid. J Clin Microbiol (1990) 0.79
New rapid identification test for Clostridium difficile. J Clin Pathol (1992) 0.75
Comparison of culture, cytotoxin assay and two EIA tests with clinical diagnosis of Clostridium difficile-associated diarrhea. Can J Infect Dis (1994) 0.75
Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays. J Clin Microbiol (1992) 0.75
Re: Salvaging a linear staple line defect in ultra-low anterior resection. Tech Coloproctol (2008) 0.75
Mammalian epithelial cell line kit for detection of Clostridium difficile toxin. J Clin Microbiol (1993) 0.75
Identification of common molecular subsequences. J Mol Biol (1981) 130.53
Comparative biosequence metrics. J Mol Evol (1981) 21.34
Statistical characterization of nucleic acid sequence functional domains. Nucleic Acids Res (1983) 20.31
On the statistical significance of nucleic acid similarities. Nucleic Acids Res (1984) 18.21
Optimal sequence alignments. Proc Natl Acad Sci U S A (1983) 14.64
Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling. Protein Eng (1992) 14.40
Automatic generation of primary sequence patterns from sets of related protein sequences. Proc Natl Acad Sci U S A (1990) 12.96
The statistical distribution of nucleic acid similarities. Nucleic Acids Res (1985) 11.99
Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1976) 9.38
Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria. Antimicrob Agents Chemother (1973) 9.35
The ancient regulatory-protein family of WD-repeat proteins. Nature (1994) 9.33
Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol (1977) 8.29
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol (1985) 7.22
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol (1984) 6.75
Uronide Deposition Rates in the Primary Root of Zea mays. Plant Physiol (1984) 6.08
Detection and serotyping of herpes simplex virus in MRC-5 cells by use of centrifugation and monoclonal antibodies 16 h postinoculation. J Clin Microbiol (1985) 6.05
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Operons in Escherichia coli: genomic analyses and predictions. Proc Natl Acad Sci U S A (2000) 5.79
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1979) 5.10
Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. N Engl J Med (2001) 5.08
Biological activities of toxins A and B of Clostridium difficile. Infect Immun (1982) 4.62
Development of a micromethod for identification of anaerobic bacteria. Appl Microbiol (1975) 4.58
Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol (2000) 4.52
How valid are medical records and patient questionnaires for physician profiling and health services research? A comparison with direct observation of patients visits. Med Care (1998) 4.16
Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol (1977) 4.09
Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06
Production of Clostridium difficile antitoxin. Infect Immun (1980) 3.95
Regulatory pattern identification in nucleic acid sequences. Nucleic Acids Res (1983) 3.90
Micromethod for identification of anaerobic bacteria: design and operation of apparatus. Appl Microbiol (1975) 3.80
Detection of Chlamydia trachomatis in genital specimens by the Chlamydiazyme test. J Clin Microbiol (1984) 3.74
Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: characterization and diagnostic application. Mayo Clin Proc (1985) 3.58
Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40
Comparison of methods for isolation of anaerobic bacteria from clinical specimens. Appl Microbiol (1973) 3.30
Effect of several components of anaerobic incubation on antibiotic susceptibility test results. Antimicrob Agents Chemother (1972) 3.29
The nature of lactose operator constitive mutations. J Mol Biol (1971) 3.14
Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. J Virol (1989) 3.11
In silico detection of control signals: mRNA 3'-end-processing sequences in diverse species. Proc Natl Acad Sci U S A (1999) 3.08
Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol (1968) 3.04
Detection of cytomegalovirus infections in specimens other than urine by the shell vial assay and conventional tube cell cultures. J Clin Microbiol (1987) 2.97
Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res (1990) 2.93
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
On the similarity of dendrograms. J Theor Biol (1978) 2.86
Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J Clin Microbiol (1982) 2.86
Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86
Development of the Resident Assessment Instrument--Mental Health (RAI-MH). Hosp Q (2001) 2.84
Oxygen tolerance of fresh clinical anaerobic bacteria. J Clin Microbiol (1975) 2.77
Risk factors for asthma in inner city children. J Pediatr (1992) 2.72
Arginine, a growth-limiting factor for Eubacterium lentum. J Bacteriol (1976) 2.67
Characterization of an established line of canine kidney cells (MDCK). Proc Soc Exp Biol Med (1966) 2.66
Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis (1991) 2.65
Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65
Production by Salmonella typhimurium of 2,3-dihydroxybenzoylserine, and its stimulation of growth in human serum. J Infect Dis (1970) 2.62
Genomic detection of new yeast pre-mRNA 3'-end-processing signals. Nucleic Acids Res (1999) 2.58
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.49
A biologically consistent model for comparing molecular phylogenies. J Comput Biol (1995) 2.48
Medium-dependent inhibition of Peptostreptococcus anaerobius by sodium polyanetholsulfonate in blood culture media. J Clin Microbiol (1976) 2.46
Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol (1985) 2.46
Evaluation of a routine anaerobic subculture of blood cultures for detection of anaerobic bacteremia. J Clin Microbiol (1978) 2.44
Mycobacteremia and the new blood culture systems. Ann Intern Med (1983) 2.39
Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc (1997) 2.36
Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob Agents Chemother (1977) 2.35
Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J Clin Microbiol (1986) 2.31
Comparison of urethral swabs, urine, and urinary sediment for the isolation of Chlamydia. J Clin Microbiol (1976) 2.23
Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother (2001) 2.23
Dependence of polymerase chain reaction product inactivation protocols on amplicon length and sequence composition. J Clin Microbiol (1993) 2.22
The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol (1998) 2.22
The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol (1995) 2.21
Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol (1999) 2.21
Evaluation of an enzyme-linked immunosorbent assay for the detection of herpes simplex virus antigen. J Clin Microbiol (1984) 2.19
Detection of herpes simplex virus DNA in genital and dermal specimens by LightCycler PCR after extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 methods. J Clin Microbiol (2001) 2.16
Consensus topography in the ATP binding site of the simian virus 40 and polyomavirus large tumor antigens. Proc Natl Acad Sci U S A (1987) 2.15
Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies. Infect Immun (1982) 2.14
Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol (2000) 2.11
G protein heterodimers: new structures propel new questions. Cell (1996) 2.10
Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med (1976) 2.09
Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza. J Clin Microbiol (1989) 2.09
Laboratory diagnosis of central nervous system infections with herpes simplex virus by PCR performed with cerebrospinal fluid specimens. J Clin Microbiol (1997) 2.08
High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet (1992) 2.06
The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect Immun (1995) 2.06
Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol (1986) 2.05
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun (1986) 2.01
Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun (1988) 2.00
Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization. Am J Med (1987) 2.00